2025 Was Not About Breakthroughs. It Was About Convergence. If 2024 was about proving the possibility of new healthcare ideas, 2025 marked the year that these innovations, across biotech, genomics, diagnostics, digital...read more
Category - Drug discovery
Invert launches Invert Assist, an AI-powered analysis interface built for bioprocess
ISAN FRANCISCO, CA, October 28, 2025 – Invert, a pioneer in AI-driven bioprocess software solutions, today announced the launch of Invert Assist, an AI-powered analysis interface for bioprocess that enables users to...read more
New Therapy Potential of Targeted Protein Degradation
New approaches in drug discovery currently focus on the concept of a „magic bullet“ molecule. One that precisely targets an intended pharmacological role without off-target actions or unwanted side-effects. Traditional...read more
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines New offering expands Lilly Catalyze360’s support for early-stage drug development INDIANAPOLIS, Sept...read more
